Manufacturers of the 10 medications listed under the novel Medicare price-negotiation program exploited patent laws to keep costs high for patients, according to a new report from the watchdog group Accountable.US.
The report comes nearly two years after… Biden signed the Inflation Reduction Act and with it launched the historic Medicare negotiation program, which allows the Department of Health and Human Services to directly negotiate with drug companies to lower the prices of some of the most expensive but commonly used prescription drugs. Continue reading